In mouse models of HD, alterations in the expression and function of NKCC1 and KCC2 have been observed in the hippocampus and striatum, leading to weakened inhibition and paradoxical excitatory actions of GABA [12]. This evidence concerns the gene SLC12A2 and Huntington disease.